+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Methylation Analysis Service Market - Global Forecast to 2030- Product Image
DNA Methylation Analysis Service Market - Global Forecast to 2030- Product Image
New

DNA Methylation Analysis Service Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079229
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
DNA methylation sits at the forefront of epigenetic research, playing a pivotal role in regulating gene expression, cellular differentiation, and disease progression. As researchers delve deeper into the epigenome, high-resolution analysis of methylation patterns has become indispensable for unraveling mechanisms underlying cancer, neurological disorders, autoimmune conditions, and beyond. Technological advances have catalyzed demand for comprehensive, accurate, and cost-effective services that span from bisulfite sequencing to immunoprecipitation and restriction enzyme-based methods. Moreover, the convergence of epigenetics with multi-omics approaches is unlocking novel insights into biomarker discovery and therapeutic target identification. This executive summary provides decision-makers with a clear overview of current market dynamics, transformative trends, regulatory pressures, and competitive landscapes shaping the global DNA methylation analysis ecosystem. Through actionable recommendations and regional, segmentation, and company insights, stakeholders will gain the clarity needed to navigate complexity, drive innovation, and secure a competitive edge in this rapidly evolving domain.

Transformative Shifts Driving the DNA Methylation Market

The landscape for DNA methylation analysis is undergoing transformative shifts driven by next-generation sequencing, AI-enabled data interpretation, and the rise of single-cell and real-time platforms. Reduced representation bisulfite sequencing and whole-genome bisulfite sequencing now deliver base-resolution insights at unprecedented throughput. Concurrently, high-resolution melting, methylated DNA immunoprecipitation, and restriction enzyme-based assays have evolved with automation and microfluidics to support high-volume screening. Artificial intelligence algorithms are refining pattern recognition, accelerating the discovery of epigenetic signatures in oncology, neurology, and immunology. Single-cell methylation profiling is redefining heterogeneity analysis, while nanopore sequencing offers real-time methylation detection without bisulfite conversion. Regulatory frameworks are maturing to ensure assay standardization and data integrity, especially as diagnostics and companion tests move toward clinical adoption. Collectively, these shifts are fueling strategic partnerships between technology providers, academic consortia, and pharmaceutical companies, fostering an ecosystem of innovation that will shape the next decade of epigenetic research.

Cumulative Impact of United States Tariffs on Market Dynamics

In 2025, the implementation of new United States tariffs on imported reagents, kits, and instrumentation has reshaped cost structures and supply chain strategies. Companies reliant on overseas manufacturing have experienced margin compression, prompting shifts toward regional sourcing, inventory rationalization, and renegotiated supplier contracts. To mitigate cost increases, service providers are exploring in-house reagent production and licensing agreements with domestic manufacturers. These adjustments are accelerating consolidation among smaller players while stimulating capacity expansion by established instrument suppliers within North America. Healthcare and research institutions face budgetary pressures, forcing them to optimize assay portfolios and negotiate volume-based pricing. Simultaneously, alternative sourcing from tariff-exempt countries, coupled with streamlined customs protocols, is gaining traction. While short-term challenges include price volatility and extended lead times, the enforced localization of manufacturing is expected to enhance supply stability and foster long-term resilience across the methylation analysis market.

Comprehensive Segmentation Insights

Detailed segmentation analysis reveals how technology, method, application, end user, sample type, targeted disease, product, protocol, and research technique collectively define the market’s architecture. On the technology front, bisulfite sequencing encompasses Pyrosequencing, reduced representation bisulfite sequencing, and whole-genome bisulfite sequencing, alongside high-resolution melting, methylated DNA immunoprecipitation, and restriction enzyme-based techniques. Methodologically, offerings branch into gene-specific and global methylation assays. Applications span academic research, drug discovery and development, non-oncology disorders-including autoimmune, cardiovascular, and neurological indications such as Alzheimer’s and Parkinson’s diseases-and oncology, covering blood, breast, colorectal, lung, and prostate cancers. End users range from clinical laboratories, contract research organizations, and research institutes to pharmaceutical and biotechnology companies focused on biomarker discovery and drug development. Sample types include blood, cell line, and tissue specimens, while targeted diseases cover cancer, epigenetic disorders, and genetic diseases. Product categories comprise instruments, reagents and kits, and software and services-featuring data analysis tools, integration software, and maintenance services. Protocols divide into direct and indirect methods, and research techniques include DNA bisulfite conversion, methylation arrays, and methylation-specific PCR. This multi-dimensional segmentation underscores diverse growth pockets and highlights areas for targeted investment and product innovation.

Key Regional Insights

Regional dynamics underscore distinct growth trajectories and strategic priorities. In the Americas, robust research funding, extensive biopharma activity, and advanced clinical infrastructure position North America as the largest market, with the United States driving demand for high-throughput sequencing and clinical-grade assays. Canada’s academic and public health institutions further contribute to early-stage innovation. Europe, the Middle East, and Africa collectively benefit from pan-regional collaborations, harmonized regulations, and strong government support for precision medicine initiatives. The European Union’s regulatory alignment and Middle Eastern investment in research hubs are expanding access to epigenetic services, while Africa’s emerging diagnostic networks present untapped potential. In Asia-Pacific, rapid expansion in China, Japan, and India is propelled by increasing R&D expenditures, rising incidence of cancer and chronic diseases, and growing adoption of genomics in healthcare. Strategic partnerships with local manufacturers and research consortia are enhancing cost efficiencies and driving tailored solutions for diverse patient populations across the region.

Leading Company Profiles and Strategic Focus

The competitive landscape features a blend of established multinationals and specialized innovators. Active Motif Inc. and Agilent Technologies, Inc. lead with comprehensive reagent portfolios and assay kits, while Bioneer Corporation and Diagenode S.A. specialize in proprietary enrichment methods and microarray platforms. EpigenDx, Inc. and Illumina Inc. deliver integrated service offerings that combine sequencing and data analysis. New England Biolabs Inc. provides optimized enzymatic workflows, and Oxford Nanopore Technologies Ltd. pioneers real-time, label-free methylation detection. PerkinElmer, Inc. and Qiagen N.V. supply end-to-end solutions spanning sample preparation to bioinformatics. Roche Holding AG and SeqOnce Biosciences, Inc. focus on clinical applications and single-cell methylation analysis, and Thermo Fisher Scientific Inc. maintains market leadership through extensive instrumentation, reagents, and informatics. Zymo Research Corp. completes the landscape with user-friendly kits for sample processing and conversion. Collectively, these players drive technological innovation, foster strategic alliances, and set quality benchmarks that define market standards.

Actionable Recommendations for Industry Leaders

To capitalize on evolving market conditions, industry leaders must adopt a multi-pronged strategy. First, diversify sourcing and accelerate in-region manufacturing to mitigate tariff impacts and ensure supply chain resilience. Second, invest in artificial intelligence and machine learning capabilities to enhance methylation data interpretation and deliver predictive insights for clinical and research applications. Third, expand single-cell and real-time sequencing offerings to address demand for high-resolution and rapid turnaround assays. Fourth, develop modular assay platforms that support both gene-specific and global methylation analysis, catering to diverse end-user needs from academic labs to pharmaceutical R&D. Fifth, pursue strategic partnerships with regional distributors, research consortia, and regulatory bodies to streamline market entry and reinforce compliance. Finally, target underserved segments such as neurological disorders and pediatric epigenetic conditions by customizing assay sensitivity and workflow efficiency. By executing these recommendations, leaders can strengthen market position, drive revenue growth, and shape the future of epigenetic research and diagnostics.

Conclusion and Strategic Outlook

DNA methylation analysis stands at a crossroads of technological innovation, regulatory evolution, and shifting economic pressures. The convergence of high-throughput sequencing, AI-driven analytics, and single-cell approaches is unlocking unprecedented insights into gene regulation, disease mechanisms, and therapeutic targets. At the same time, tariff-induced cost dynamics and regional supply chain realignments demand proactive risk management and localization strategies. Understanding detailed segmentation and regional nuances empowers stakeholders to tailor solutions for specific research and clinical needs. Collaboration between technology providers, service organizations, and end users will be essential to drive standardization, accelerate validation, and scale adoption. As market leaders refine their product portfolios and forge strategic partnerships, the path forward will be defined by agility, innovation, and a relentless focus on delivering precise, reproducible, and cost-effective epigenetic assays. These collective actions will not only shape competitive advantage but also contribute to breakthroughs in precision medicine and public health.

Market Segmentation & Coverage

This research report categorizes the DNA Methylation Analysis Service Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Bisulfite Sequencing
    • Pyrosequencing
    • Reduced Representation Bisulfite Sequencing
    • Whole Genome Bisulfite Sequencing
  • High-Resolution Melting
  • Methylated DNA Immunoprecipitation
  • Restriction Enzyme-Based Techniques
  • Gene-Specific DNA Methylation
  • Global DNA Methylation
  • Academic Research
  • Drug Discovery & Development
  • Non-Oncology Disorders
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Neurological Disorders
      • Alzheimer’s Disease
      • Parkinson’s Disease
  • Oncology
    • Blood Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Prostate Cancer
  • Clinical Laboratories
  • Contract Research Organizations
  • Pharmaceutical & Biotechnology Companies
    • Biomarker Discovery
    • Drug Development
  • Research Institutes
  • Blood Samples
  • Cell Line Samples
  • Tissue Samples
  • Cancer
  • Epigenetic Disorders
  • Genetic Disorders
  • Instruments
  • Reagents & Kits
  • Software & Services
    • Data Analysis Tools
    • Integration Software
    • Maintenance Services
  • Direct Method
  • Indirect Method
  • DNA Bisulfite Conversion
  • Methylation Arrays
  • Methylation-Specific PCR

This research report categorizes the DNA Methylation Analysis Service Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the DNA Methylation Analysis Service Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Active Motif Inc.
  • Agilent Technologies, Inc.
  • Bioneer Corporation
  • Diagenode S.A.
  • EpigenDx, Inc.
  • Illumina Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Roche Holding AG
  • SeqOnce Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. DNA Methylation Analysis Service Market, by Technology
8.1. Introduction
8.2. Bisulfite Sequencing
8.2.1. Pyrosequencing
8.2.2. Reduced Representation Bisulfite Sequencing
8.2.3. Whole Genome Bisulfite Sequencing
8.3. High-Resolution Melting
8.4. Methylated DNA Immunoprecipitation
8.5. Restriction Enzyme-Based Techniques
9. DNA Methylation Analysis Service Market, by Method
9.1. Introduction
9.2. Gene-Specific DNA Methylation
9.3. Global DNA Methylation
10. DNA Methylation Analysis Service Market, by Application
10.1. Introduction
10.2. Academic Research
10.3. Drug Discovery & Development
10.4. Non-Oncology Disorders
10.4.1. Autoimmune Diseases
10.4.2. Cardiovascular Diseases
10.4.3. Neurological Disorders
10.4.3.1. Alzheimer’s Disease
10.4.3.2. Parkinson’s Disease
10.5. Oncology
10.5.1. Blood Cancer
10.5.2. Breast Cancer
10.5.3. Colorectal Cancer
10.5.4. Lung Cancer
10.5.5. Prostate Cancer
11. DNA Methylation Analysis Service Market, by End User
11.1. Introduction
11.2. Clinical Laboratories
11.3. Contract Research Organizations
11.4. Pharmaceutical & Biotechnology Companies
11.4.1. Biomarker Discovery
11.4.2. Drug Development
11.5. Research Institutes
12. DNA Methylation Analysis Service Market, by Sample Type
12.1. Introduction
12.2. Blood Samples
12.3. Cell Line Samples
12.4. Tissue Samples
13. DNA Methylation Analysis Service Market, by Targeted Diseases
13.1. Introduction
13.2. Cancer
13.3. Epigenetic Disorders
13.4. Genetic Disorders
14. DNA Methylation Analysis Service Market, by Product
14.1. Introduction
14.2. Instruments
14.3. Reagents & Kits
14.4. Software & Services
14.4.1. Data Analysis Tools
14.4.2. Integration Software
14.4.3. Maintenance Services
15. DNA Methylation Analysis Service Market, by Protocol
15.1. Introduction
15.2. Direct Method
15.3. Indirect Method
16. DNA Methylation Analysis Service Market, by Research Technique
16.1. Introduction
16.2. DNA Bisulfite Conversion
16.3. Methylation Arrays
16.4. Methylation-Specific PCR
17. Americas DNA Methylation Analysis Service Market
17.1. Introduction
17.2. Argentina
17.3. Brazil
17.4. Canada
17.5. Mexico
17.6. United States
18. Asia-Pacific DNA Methylation Analysis Service Market
18.1. Introduction
18.2. Australia
18.3. China
18.4. India
18.5. Indonesia
18.6. Japan
18.7. Malaysia
18.8. Philippines
18.9. Singapore
18.10. South Korea
18.11. Taiwan
18.12. Thailand
18.13. Vietnam
19. Europe, Middle East & Africa DNA Methylation Analysis Service Market
19.1. Introduction
19.2. Denmark
19.3. Egypt
19.4. Finland
19.5. France
19.6. Germany
19.7. Israel
19.8. Italy
19.9. Netherlands
19.10. Nigeria
19.11. Norway
19.12. Poland
19.13. Qatar
19.14. Russia
19.15. Saudi Arabia
19.16. South Africa
19.17. Spain
19.18. Sweden
19.19. Switzerland
19.20. Turkey
19.21. United Arab Emirates
19.22. United Kingdom
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Active Motif Inc.
20.3.2. Agilent Technologies, Inc.
20.3.3. Bioneer Corporation
20.3.4. Diagenode S.A.
20.3.5. EpigenDx, Inc.
20.3.6. Illumina Inc.
20.3.7. New England Biolabs Inc.
20.3.8. Oxford Nanopore Technologies Ltd.
20.3.9. PerkinElmer, Inc.
20.3.10. Qiagen N.V.
20.3.11. Roche Holding AG
20.3.12. SeqOnce Biosciences, Inc.
20.3.13. Thermo Fisher Scientific Inc.
20.3.14. Zymo Research Corp.
21. ResearchAI
22. ResearchStatistics
23. ResearchContacts
24. ResearchArticles
25. Appendix
List of Figures
FIGURE 1. DNA METHYLATION ANALYSIS SERVICE MARKET MULTI-CURRENCY
FIGURE 2. DNA METHYLATION ANALYSIS SERVICE MARKET MULTI-LANGUAGE
FIGURE 3. DNA METHYLATION ANALYSIS SERVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 20. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2024 VS 2030 (%)
FIGURE 22. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2024 VS 2030 (%)
FIGURE 24. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 28. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. EUROPE, MIDDLE EAST & AFRICA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. EUROPE, MIDDLE EAST & AFRICA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. DNA METHYLATION ANALYSIS SERVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 34. DNA METHYLATION ANALYSIS SERVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DNA METHYLATION ANALYSIS SERVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PYROSEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY REDUCED REPRESENTATION BISULFITE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY WHOLE GENOME BISULFITE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY HIGH-RESOLUTION MELTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHYLATED DNA IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESTRICTION ENZYME-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY GENE-SPECIFIC DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY GLOBAL DNA METHYLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY CELL LINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY EPIGENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY DATA ANALYSIS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY INTEGRATION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY DIRECT METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY INDIRECT METHOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY DNA BISULFITE CONVERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHYLATION ARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHYLATION-SPECIFIC PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 113. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 115. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 116. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 118. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 119. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 120. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 122. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 123. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 124. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 126. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 127. CANADA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 130. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 131. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 142. MEXICO DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 159. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 161. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 162. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 164. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 175. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 177. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 178. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 180. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 181. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 190. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 192. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 193. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 195. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 196. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 197. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 199. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 200. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 201. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 203. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 204. CHINA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 205. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 207. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 208. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 210. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 211. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 212. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 214. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 216. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 218. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 219. INDIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 220. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 222. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 223. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 225. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 226. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 227. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 235. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 237. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 238. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 240. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 241. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 242. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 244. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 246. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 248. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 249. JAPAN DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 265. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 267. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 268. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 270. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 271. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 272. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 274. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 276. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 278. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 280. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY BISULFITE SEQUENCING, 2018-2030 (USD MILLION)
TABLE 282. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 283. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NON-ONCOLOGY DISORDERS, 2018-2030 (USD MILLION)
TABLE 285. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 286. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 287. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
TABLE 289. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 290. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY TARGETED DISEASES, 2018-2030 (USD MILLION)
TABLE 291. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 293. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY PROTOCOL, 2018-2030 (USD MILLION)
TABLE 294. SINGAPORE DNA METHYLATION ANALYSIS SERVICE MARKET SIZE, BY RESEARCH TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 295.

Companies Mentioned

  • Active Motif Inc.
  • Agilent Technologies, Inc.
  • Bioneer Corporation
  • Diagenode S.A.
  • EpigenDx, Inc.
  • Illumina Inc.
  • New England Biolabs Inc.
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Roche Holding AG
  • SeqOnce Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.

Methodology

Loading
LOADING...

Related Topics

Related Reports

DNA Methylation - Global Strategic Business Report - Product Image

DNA Methylation - Global Strategic Business Report

  • Report
  • 207 Pages
  • Global
From
United States Nutrigenomics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

United States Nutrigenomics Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 70 Pages
  • United States
From
North America Optical Genome Mapping Market, By Country, Competition, Forecast and Opportunities, 2020-2030F - Product Image

North America Optical Genome Mapping Market, By Country, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 120 Pages
  • North America
From
U.S. Epigenetics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits), Technology (DNA Methylation, Histone Methylation), Application (Oncology, Non-oncology), End-use, and Segment Forecasts, 2024-2030 - Product Image

U.S. Epigenetics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits), Technology (DNA Methylation, Histone Methylation), Application (Oncology, Non-oncology), End-use, and Segment Forecasts, 2024-2030

  • Report
  • 90 Pages
  • United States
From
DNA Methylation Market Report by Product, Technology, Application, End User, and Region 2025-2033 - Product Image

DNA Methylation Market Report by Product, Technology, Application, End User, and Region 2025-2033

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.